Health ❯Healthcare ❯Pharmaceuticals

Weight Loss Drugs

Dietary Changes Food and Drug Administration Weight Loss Nutrition Consultation Drug Safety Type 2 Diabetes Pharmacy Services Public Health Global Health

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves

Novo Nordisk and Cigna introduce temporary discounts and copay caps as compounded semaglutide distribution ceases under new FDA regulations.

‘Ozempic Teeth’ Emerges as a Serious Dental Risk for Weight-Loss Drug Users

WHO to Endorse GLP-1 Weight-Loss Drugs, Calls for Global Access

FDA Seizes Counterfeit Ozempic in U.S. Supply Chain

Hims & Hers Expands Weight-Loss Offerings with New Medications

Novo Nordisk Acquires Chinese Obesity Drug After CagriSema Trial Disappointment

Taxpayer-Funded Weight-Loss Drugs Face Scrutiny Over High Prices

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices